Studies on anticancer activities of antimicrobial peptides.

[1]  Sreeja,et al.  Deletion of All Cysteines in Tachyplesin I Abolishes Hemolytic Activity and Retains Antimicrobial Activity and LPS Selective Binding , 2008 .

[2]  H. Jenssen,et al.  The anti-papillomavirus activity of human and bovine lactoferricin. , 2007, Antiviral research.

[3]  D. Hoskin,et al.  Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. , 2007, Experimental cell research.

[4]  C. Toniolo,et al.  Alamethicin Interaction with Lipid Membranes: A Spectroscopic Study on Synthetic Analogues , 2007, Chemistry & biodiversity.

[5]  R. Hancock,et al.  Characterization of the structure and membrane interaction of the antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs. , 2007, Biophysical journal.

[6]  G. Pirri,et al.  Antimicrobial peptides: an overview of a promising class of therapeutics , 2007, Central European Journal of Biology.

[7]  D. Hoskin,et al.  Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. , 2006, The American journal of pathology.

[8]  A. Ulrich,et al.  Synergistic Transmembrane Alignment of the Antimicrobial Heterodimer PGLa/Magainin* , 2006, Journal of Biological Chemistry.

[9]  G. Lorigan,et al.  Exploring membrane selectivity of the antimicrobial peptide KIGAKI using solid-state NMR spectroscopy. , 2006, Biochimica et biophysica acta.

[10]  Y. Shai,et al.  Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. , 2006, Biochimica et biophysica acta.

[11]  Ayyalusamy Ramamoorthy,et al.  LL-37, the only human member of the cathelicidin family of antimicrobial peptides. , 2006, Biochimica et biophysica acta.

[12]  A. Ulrich,et al.  Conditions affecting the re-alignment of the antimicrobial peptide PGLa in membranes as monitored by solid state 2H-NMR. , 2006, Biochimica et biophysica acta.

[13]  Ayyalusamy Ramamoorthy,et al.  The human beta-defensin-3, an antibacterial peptide with multiple biological functions. , 2006, Biochimica et biophysica acta.

[14]  B. Bechinger,et al.  Detergent-like actions of linear amphipathic cationic antimicrobial peptides. , 2006, Biochimica et biophysica acta.

[15]  K. Henzler-Wildman,et al.  Expression and purification of a recombinant LL-37 from Escherichia coli. , 2006, Biochimica et biophysica acta.

[16]  H. Vogel,et al.  Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. , 2006, Biochimica et biophysica acta.

[17]  W. Brey,et al.  Investigating molecular recognition and biological function at interfaces using piscidins, antimicrobial peptides from fish. , 2006, Biochimica et biophysica acta.

[18]  H. Won,et al.  Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5. , 2006, Journal of medicinal chemistry.

[19]  B. Sveinbjørnsson,et al.  The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo , 2006, International journal of cancer.

[20]  Fionnuala T Lundy,et al.  The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. , 2006, Oral oncology.

[21]  R. Weissleder,et al.  A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity , 2006, Molecular Cancer Therapeutics.

[22]  D. Hoskin,et al.  Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment , 2006, Expert opinion on investigational drugs.

[23]  Friedrich Paulsen,et al.  Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. , 2006, European urology.

[24]  Ayyalusamy Ramamoorthy,et al.  Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. , 2006, Biophysical journal.

[25]  L. Cruz-Chamorro,et al.  In vitro biological activities of magainin alone or in combination with nisin , 2006, Peptides.

[26]  Ayyalusamy Ramamoorthy,et al.  Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding. , 2006, Biochemistry.

[27]  Vyacheslav Kalchenko,et al.  Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. , 2006, Cancer research.

[28]  D. Hoskin,et al.  Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. , 2006, Oncology reports.

[29]  G. Veglia,et al.  Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. , 2006, Biochemistry.

[30]  Guangshun Wang,et al.  Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. , 2006, Journal of the American Chemical Society.

[31]  S. Ye,et al.  Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. , 2006, The American journal of pathology.

[32]  Qi-Fu Li,et al.  Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823. , 2006, World journal of gastroenterology.

[33]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[34]  U. Dürr,et al.  Solid-state NMR analysis of the PGLa peptide orientation in DMPC bilayers: structural fidelity of 2H-labels versus high sensitivity of 19F-NMR. , 2006, Biophysical journal.

[35]  A. Krensky,et al.  Cell selectivity correlates with membrane-specific interactions: a case study on the antimicrobial peptide G15 derived from granulysin. , 2006, Biochimica et biophysica acta.

[36]  F. Separovic,et al.  Membrane interactions of antimicrobial peptides from Australian tree frogs. , 2006, Biochimica et biophysica acta.

[37]  M. B. Banaszak Holl,et al.  Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. , 2005, Biophysical journal.

[38]  Gifford Jl,et al.  Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. , 2005 .

[39]  Deborah Schrag,et al.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. , 2005, Journal of the National Cancer Institute.

[40]  S. Straus,et al.  Interaction of alamethicin with ether-linked phospholipid bilayers: oriented circular dichroism, 31P solid-state NMR, and differential scanning calorimetry studies. , 2005, Biophysical journal.

[41]  J. Vederas,et al.  Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. , 2005, Chemistry and physics of lipids.

[42]  Z. Figaszewski,et al.  Changes in electric charge and phospholipids composition in human colorectal cancer cells , 2005, Molecular and Cellular Biochemistry.

[43]  U. Karsten,et al.  What Makes MUC1 a Tumor Antigen? , 2005, Tumor Biology.

[44]  A. Ramamoorthy,et al.  Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. , 2005, Biochimica et biophysica acta.

[45]  Lurong Zhang,et al.  Tachyplesin activates the classic complement pathway to kill tumor cells. , 2005, Cancer research.

[46]  Y. Shai,et al.  Host defense peptides as new weapons in cancer treatment , 2005, Cellular and Molecular Life Sciences CMLS.

[47]  David M. Conrad,et al.  Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines , 2005, Molecular Cancer Therapeutics.

[48]  C. Maxwell,et al.  Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. , 2005, Current drug targets. Cardiovascular & haematological disorders.

[49]  F. Zunino,et al.  Overview of tumor cell chemoresistance mechanisms. , 2005, Methods in molecular medicine.

[50]  H. Vogel,et al.  Lactoferricin , 2005, Cellular and Molecular Life Sciences.

[51]  D. Tosteson,et al.  Melittin lysis of red cells , 2005, The Journal of Membrane Biology.

[52]  C. Ling,et al.  Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[53]  T. Kaku,et al.  Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. , 2004, Journal of dermatological science.

[54]  Gianluigi Veglia,et al.  Structure and Orientation of Pardaxin Determined by NMR Experiments in Model Membranes* , 2004, Journal of Biological Chemistry.

[55]  A. Waring,et al.  Solid-state NMR investigation of the selective disruption of lipid membranes by protegrin-1. , 2004, Biochemistry.

[56]  H. Jenssen,et al.  Anti‐HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface , 2004, Journal of medical virology.

[57]  Hiroshi Isogai,et al.  C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. , 2004, Cancer letters.

[58]  Y. Shai,et al.  Suppression of Human Prostate Tumor Growth in Mice by a Cytolytic d-, l-Amino Acid Peptide , 2004, Cancer Research.

[59]  H. Hammes,et al.  Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  F. Sheu,et al.  Induction of transient ion channel-like pores in a cancer cell by antibiotic peptide. , 2004, Journal of biochemistry.

[61]  C. Leuschner,et al.  Membrane disrupting lytic peptides for cancer treatments. , 2004, Current pharmaceutical design.

[62]  Michael F. Brown,et al.  Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. , 2004, Biochemistry.

[63]  P. F. Almeida,et al.  Kinetics of Dye Efflux and Lipid Flip-Flop Induced by δ-Lysin in Phosphatidylcholine Vesicles and the Mechanism of Graded Release by Amphipathic, α-Helical Peptides† , 2004 .

[64]  J. Svendsen,et al.  The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells , 2004, Journal of peptide science : an official publication of the European Peptide Society.

[65]  Jason L. Townson,et al.  Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases , 2003, Breast Cancer Research and Treatment.

[66]  J. Taylor‐Papadimitriou,et al.  MUC1 and the Immunobiology of Cancer , 2002, Journal of mammary gland biology and neoplasia.

[67]  Joy Joseph,et al.  Doxorubicin-induced apoptosis: Implications in cardiotoxicity , 2002, Molecular and Cellular Biochemistry.

[68]  J. Taylor‐Papadimitriou,et al.  O-Linked Glycosylation in the Mammary Gland: Changes that Occur During Malignancy , 2001, Journal of Mammary Gland Biology and Neoplasia.

[69]  P. F. Almeida,et al.  Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides. , 2004, Biochemistry.

[70]  J. Werkmeister,et al.  Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies , 2004, Cancer Immunology, Immunotherapy.

[71]  E. Espinosa,et al.  Classification of anticancer drugs--a new system based on therapeutic targets. , 2003, Cancer treatment reviews.

[72]  B. Haug,et al.  Enhanced antitumour activity of 15‐residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N‐terminal modifications , 2003, Journal of peptide science : an official publication of the European Peptide Society.

[73]  Niv Papo,et al.  New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells. , 2003, Biochemistry.

[74]  Y. Bang,et al.  In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines , 2003, Peptides.

[75]  Niv Papo,et al.  A Novel Lytic Peptide Composed of dl-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice* , 2003, Journal of Biological Chemistry.

[76]  Dong-Kuk Lee,et al.  Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. , 2003, Biochemistry.

[77]  A. Ramamoorthy,et al.  MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. , 2003, Biophysical journal.

[78]  L. Llewellyn,et al.  nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. The solution structure of a modified citropin 1.1. , 2003, European journal of biochemistry.

[79]  S. Yonehara,et al.  Translocation of Analogues of the Antimicrobial Peptides Magainin and Buforin across Human Cell Membranes* , 2003, The Journal of Biological Chemistry.

[80]  T. Wagner,et al.  A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. , 2003, International journal of oncology.

[81]  Robert Bals,et al.  Antimicrobial Peptides , 2012, Drugs.

[82]  Frances Separovic,et al.  Interaction of antimicrobial peptides from Australian amphibians with lipid membranes. , 2003, Chemistry and physics of lipids.

[83]  Qing-Rong Liu,et al.  Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells. , 2002, World journal of gastroenterology.

[84]  J. Cassidy,et al.  Oxaliplatin-related side effects: characteristics and management. , 2002, Seminars in oncology.

[85]  Hueih Min Chen,et al.  The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells. , 2002, Anticancer research.

[86]  J. Svendsen,et al.  Evidence for a direct antitumor mechanism of action of bovine lactoferricin. , 2002, Anticancer research.

[87]  T. Tachi,et al.  Dimer structure of magainin 2 bound to phospholipid vesicles. , 2002, Biopolymers.

[88]  Dong-Kuk Lee,et al.  Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. , 2002, Biophysical journal.

[89]  V. Kähäri,et al.  Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets , 2002, International journal of cancer.

[90]  M. Deeg,et al.  Human α-Defensins HNPs-1, -2, and -3 in Renal Cell Carcinoma : Influences on Tumor Cell Proliferation , 2002 .

[91]  Robert E W Hancock,et al.  Cationic peptides: distribution and mechanisms of resistance. , 2002, Current pharmaceutical design.

[92]  Paolo Bernardi,et al.  BMAP-28, an Antibiotic Peptide of Innate Immunity, Induces Cell Death through Opening of the Mitochondrial Permeability Transition Pore , 2002, Molecular and Cellular Biology.

[93]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[94]  M. Aubrey.  B1: The involvement of bisecting n-acetylglucosamine in cancer , 2002 .

[95]  Y. Shai,et al.  Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.

[96]  E J Park,et al.  Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. , 2001, The journal of peptide research : official journal of the American Peptide Society.

[97]  J. Mai,et al.  A proapoptotic peptide for the treatment of solid tumors. , 2001, Cancer research.

[98]  Koji Tanaka,et al.  PI3‐kinase p85α Is a Target Molecule of Proline‐rich Antimicrobial Peptide to Suppress Proliferation of ras‐Transformed Cells , 2001, Japanese journal of cancer research : Gann.

[99]  T. Traavik,et al.  Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. , 2001, Antiviral research.

[100]  A. I. Arunkumar,et al.  Crumpled structure of the custom hydrophobic lytic peptide cecropin B3. , 2001, European journal of biochemistry.

[101]  J. Calafat,et al.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.

[102]  Y. Chen,et al.  RGD-Tachyplesin inhibits tumor growth. , 2001, Cancer research.

[103]  S. White,et al.  Structure, location, and lipid perturbations of melittin at the membrane interface. , 2001, Biophysical journal.

[104]  R. Gennaro,et al.  Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39. , 2001, The Journal of investigative dermatology.

[105]  M. Aubery.  Glycans in cell interaction and recognition : therapeutic aspects , 2001 .

[106]  E. Ikonen,et al.  How cells handle cholesterol. , 2000, Science.

[107]  Qi-Fu Li,et al.  Effects of tachyplesin on the morphology and ultrastructure of human gastric carcinoma cell line BGC-823. , 2000, World journal of gastroenterology.

[108]  R. Hancock,et al.  The role of cationic antimicrobial peptides in innate host defences. , 2000, Trends in microbiology.

[109]  J. Carver,et al.  The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. , 2000, European journal of biochemistry.

[110]  A. Mor.  Peptide‐based antibiotics: A potential answer to raging antimicrobial resistance , 2000 .

[111]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[112]  Y. Shai,et al.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.

[113]  S. Chan,et al.  Membrane lysis by the antibacterial peptides cecropins B1 and B3: A spin-label electron spin resonance study on phospholipid bilayers. , 1999, Biophysical journal.

[114]  G. Otting,et al.  Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK‐lysin , 1999, FEBS letters.

[115]  S. Saini,et al.  Melittin activates endogenous phospholipase D during cytolysis of human monocytic leukemia cells. , 1999, Toxicon : official journal of the International Society on Toxinology.

[116]  M. Ono,et al.  Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells , 1999, British Journal of Cancer.

[117]  Erkki Ruoslahti,et al.  Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.

[118]  Y. Shai,et al.  Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. , 1999, The Biochemical journal.

[119]  M. Sentjurc,et al.  Membrane fluidity characteristics of human lung cancer. , 1999, Cancer letters.

[120]  K. Hahm,et al.  NMR structural characterization of cecropin A(1-8) - magainin 2(1-12) and cecropin A (1-8) - melittin (1-12) hybrid peptides. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[121]  M. Ståhle-Bäckdahl,et al.  The Human Cationic Antimicrobial Protein (hCAP18), a Peptide Antibiotic, Is Widely Expressed in Human Squamous Epithelia and Colocalizes with Interleukin-6 , 1999, Infection and Immunity.

[122]  D. Craik,et al.  Conformational studies by NMR of the antimicrobial peptide, drosocin, and its non-glycosylated derivative: effects of glycosylation on solution conformation. , 1999, Biochemistry.

[123]  A. Rao,et al.  Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. , 1999, Archives of biochemistry and biophysics.

[124]  B Kwiatkowski,et al.  ESR study of plasmatic membrane of the transplantable melanoma cells in relation to their biological properties. , 1999, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[125]  K. Hahm,et al.  Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[126]  Gupta,et al.  The concentration-dependent membrane activity of cecropin A , 1999, Biochemistry.

[127]  S. Chan,et al.  Microscopic observations of the different morphological changes caused by anti‐bacterial peptides on Klebsiella pneumoniae and HL‐60 leukemia cells , 1998, Journal of peptide science : an official publication of the European Peptide Society.

[128]  R. Gennaro,et al.  Cytotoxicity and apoptosis mediated by two peptides of innate immunity. , 1998, Cellular immunology.

[129]  R. Gallo,et al.  PR-39, a Syndecan-inducing Antimicrobial Peptide, Binds and Affects p130Cas * , 1998, The Journal of Biological Chemistry.

[130]  H. Vogel,et al.  Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. , 1998, Biochemistry.

[131]  K. Berndt,et al.  Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37* , 1998, The Journal of Biological Chemistry.

[132]  S. Opella,et al.  Structure and dynamics of the antibiotic peptide PGLa in membranes by solution and solid-state nuclear magnetic resonance spectroscopy. , 1998, Biophysical journal.

[133]  Brian Salmons,et al.  Expression of antimicrobial peptides has an antitumour effect in human cells. , 1998, Biochemical and biophysical research communications.

[134]  Y. Shai,et al.  Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .

[135]  K. Hahm,et al.  Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[136]  N. Yoshida,et al.  A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection , 1997, The Journal of experimental medicine.

[137]  M. Hollingsworth,et al.  Oligosaccharides Expressed on MUC1 Produced by Pancreatic and Colon Tumor Cell Lines* , 1997, The Journal of Biological Chemistry.

[138]  P. Axelsen,et al.  The concentration-dependent membrane activity of cecropin A. , 1997, Biochemistry.

[139]  Y. Yoo,et al.  Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species. , 1997, Biochemical and biophysical research communications.

[140]  S. Chan,et al.  Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells. , 1997, Biochimica et biophysica acta.

[141]  Jiang Hong,et al.  A Repertoire of Novel Antibacterial Diastereomeric Peptides with Selective Cytolytic Activity* , 1997, The Journal of Biological Chemistry.

[142]  Y. Yoo,et al.  Bovine Lactoferrin and Lactoferricin, a Peptide Derived from Bovine Lactoferrin, Inhibit Tumor Metastasis in Mice , 1997, Japanese journal of cancer research : Gann.

[143]  D. Bainton,et al.  The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. , 1997, Blood.

[144]  L. Bagella,et al.  Biological Characterization of Two Novel Cathelicidin-derived Peptides and Identification of Structural Requirements for Their Antimicrobial and Cell Lytic Activities* , 1996, The Journal of Biological Chemistry.

[145]  N. Fujii,et al.  An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.

[146]  W. Yoon,et al.  Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. , 1996, Biochemical and biophysical research communications.

[147]  D. S. McVey,et al.  Antibacterial activity of a synthetic peptide (PR-26) derived from PR-39, a proline-arginine-rich neutrophil antimicrobial peptide , 1996, Antimicrobial agents and chemotherapy.

[148]  Y. Shai.  Molecular recognition between membrane-spanning polypeptides. , 1995, Trends in biochemical sciences.

[149]  T. Ganz,et al.  Defensins and other endogenous peptide antibiotics of vertebrates , 1995, Journal of leukocyte biology.

[150]  M. Munshi,et al.  Scanning electron microscopic analysis of breast aspirates , 1995, Cytopathology : official journal of the British Society for Clinical Cytology.

[151]  J. Larrick,et al.  Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein , 1995, Infection and immunity.

[152]  S. Kumar,et al.  The role of hyaluronan in tumour neovascularization (review) , 1995, International journal of cancer.

[153]  M. Herlyn,et al.  Experimental local therapy of human melanoma with lytic magainin peptides , 1995, International journal of cancer.

[154]  J. Jung,et al.  Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. , 1994, Biochemical and biophysical research communications.

[155]  Y. Shai,et al.  Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides , 1995, Biopolymers.

[156]  D. S. McVey,et al.  F peptide . proline-arginine-rich neutrophil antimicrobial ( PR-26 ) derived from PR-39 , a Antibacterial activity of a synthetic peptide , 1995 .

[157]  R. Perlmutter,et al.  Lactoferrin , 2015, Experimental Biology and Medicine.

[158]  M. Zasloff,et al.  Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. , 2007, Ciba Foundation symposium.

[159]  M. Bibby,et al.  Preliminary experimental anticancer activity of cecropins. , 1994, Peptide research.

[160]  S. Sui,et al.  Conformational changes of melittin upon insertion into phospholipid monolayer and vesicle. , 1994, Journal of biochemistry.

[161]  R. Sanderson,et al.  Expression of syndecan-1 inhibits cell invasion into type I collagen. , 1994, The Journal of biological chemistry.

[162]  D. Cafiso.  Alamethicin: a peptide model for voltage gating and protein-membrane interactions. , 1994, Annual review of biophysics and biomolecular structure.

[163]  S. Ludtke,et al.  Cooperative membrane insertion of magainin correlated with its cytolytic activity. , 1994, Biochimica et biophysica acta.

[164]  J. Jung,et al.  Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. , 1994, Biochemical and biophysical research communications.

[165]  F. Brian,et al.  Expression of Syndecan-1 Inhibits Cell Invasion into Type I Collagen* , 1994 .

[166]  S. Opella,et al.  Structure and orientation of the antibiotic peptide magainin in membranes by solid‐state nuclear magnetic resonance spectroscopy , 1993, Protein science : a publication of the Protein Society.

[167]  A. Zachowski.  Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. , 1993, The Biochemical journal.

[168]  M. Zasloff,et al.  Anticancer efficacy of Magainin2 and analogue peptides. , 1993, Cancer research.

[169]  Sreenath V. Sharma,et al.  Melittin-induced hyperactivation of phospholipase A2 activity and calcium influx in ras-transformed cells. , 1993, Oncogene.

[170]  T. Katsu,et al.  Mode of action of an antimicrobial peptide, tachyplesin I, on biomembranes. , 1993, Biological & pharmaceutical bulletin.

[171]  R I Lehrer,et al.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells. , 1993, Annual review of immunology.

[172]  A. Balmain,et al.  How many mutations are required for tumorigenesis? implications from human cancer data , 1993 .

[173]  T Ueda,et al.  A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II). , 1992, Biochemical and biophysical research communications.

[174]  A. Gazdar,et al.  Antitumor activity of magainin analogues against human lung cancer cell lines. , 1992, Cancer research.

[175]  K. Yamauchi,et al.  Identification of the bactericidal domain of lactoferrin. , 1992, Biochimica et biophysica acta.

[176]  S. Sharma.  Melittin resistance: a counterselection for ras transformation. , 1992, Oncogene.

[177]  R. B. Merrifield,et al.  Shortened cecropin A‐melittin hybrids Significant size reduction retains potent antibiotic activity , 1992, FEBS letters.

[178]  K. Yamauchi,et al.  Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. , 1991, Journal of dairy science.

[179]  J. W. Dennis,et al.  N-linked oligosaccharide processing and tumor cell biology. , 1991, Seminars in cancer biology.

[180]  V. Mutt,et al.  Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. , 1991, European journal of biochemistry.

[181]  J. Gera,et al.  Human neutrophil peptide defensins induce single strand DNA breaks in target cells. , 1991, Cellular immunology.

[182]  L. Tamm,et al.  Orientation of melittin in phospholipid bilayers. A polarized attenuated total reflection infrared study. , 1991, Biophysical journal.

[183]  A. Lichtenstein,et al.  Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane. , 1991, The Journal of clinical investigation.

[184]  C. Bucana,et al.  Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. , 1991, Cancer research.

[185]  J. Barker,et al.  Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[186]  D. Eisenberg,et al.  Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. , 1991, Science.

[187]  S. Iwanaga,et al.  Direct virus inactivation of tachyplesin I and its isopeptides from horseshoe crab hemocytes. , 1991, Chemotherapy.

[188]  S. Iwanaga,et al.  Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro. , 1991, Chemotherapy.

[189]  D. Tosteson,et al.  Primary structure of peptides and ion channels. Role of amino acid side chains in voltage gating of melittin channels. , 1990, Biophysical journal.

[190]  T. Ganz,et al.  Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[191]  V. Mutt,et al.  Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[192]  H. Westerhoff,et al.  Interactions between a new class of eukaryotic antimicrobial agents and isolated rat liver mitochondria. , 1989, Biochimica et biophysica acta.

[193]  M. Selsted,et al.  Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide. , 1989, The Journal of biological chemistry.

[194]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[195]  T. Miyata,et al.  Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. , 1988, The Journal of biological chemistry.

[196]  P. Kraulis,et al.  The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study. , 1988, Biochemistry.

[197]  T. Ganz,et al.  Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. , 1988, Journal of immunology.

[198]  R. B. Merrifield,et al.  Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. , 1988, Biochimica et biophysica acta.

[199]  M. Zasloff,et al.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[200]  M. Zasloff,et al.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .

[201]  D. Hultmark,et al.  Cell-free immunity in insects. , 1987, Annual review of microbiology.

[202]  T. Ganz,et al.  In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. , 1986, Blood.

[203]  J. Dunn,et al.  Differential cytolysis of murine spleen, bone-marrow and leukemia cells by melittin reveals differences in membrane topography. , 1986, Biochemical and biophysical research communications.

[204]  K. Brunson,et al.  Cytotoxicity of rabbit macrophage peptides MCP-1 and MCP-2 for mouse tumor cells , 1985, Antimicrobial Agents and Chemotherapy.

[205]  T. Ganz,et al.  DEFENSINS: NATURAL PEPTIDE ANTIBIOTICS IN HUMAN NEUTROPHILS , 1986 .

[206]  D. Tosteson,et al.  The sting. Melittin forms channels in lipid bilayers. , 1981, Biophysical journal.

[207]  D. Hultmark,et al.  Sequence and specificity of two antibacterial proteins involved in insect immunity , 1981, Nature.

[208]  I. Mandel,et al.  Clinical Science , 1980 .

[209]  L. Koss,et al.  Surface configuration of human tumor cells obtained by fine needle aspiration biopsy. , 1980, Scanning electron microscopy.

[210]  I. Mandel,et al.  Lactoferrin concentration in human parotid saliva as measured by an enzyme-linked immunosorbent assay (ELISA). , 1980, Journal of dental research.

[211]  R. Hynes.  Surfaces of normal and malignant cells , 1979 .

[212]  J. Gauldie,et al.  The structures of some peptides from bee venom. , 1978, European journal of biochemistry.

[213]  P. Masson,et al.  Lactoferrin in milk from different species. , 1971, Comparative biochemistry and physiology. B, Comparative biochemistry.

[214]  E. Schonne,et al.  LACTOFERRIN, AN IRON-BINBING PROTEIN NI NEUTROPHILIC LEUKOCYTES , 1969, The Journal of experimental medicine.

[215]  E. Schonne,et al.  LACTOFERRIN, AN IRON-BINDING P ROTEIN N I NEUTROPHILIC L EUKOCYTES* , 1969 .

[216]  E. Habermann,et al.  Sequenzanalyse des Melittins aus den tryptischen und peptischen Spaltstücken , 1967 .